Details for New Drug Application (NDA): 011316
✉ Email this page to a colleague
NDA 011316 describes TEMARIL, which is a drug marketed by Allergan Herbert and is included in one NDA. Additional details are available on the TEMARIL profile page.
The generic ingredient in TEMARIL is trimeprazine tartrate. There are five drug master file entries for this compound. Additional details are available on the trimeprazine tartrate profile page.
The generic ingredient in TEMARIL is trimeprazine tartrate. There are five drug master file entries for this compound. Additional details are available on the trimeprazine tartrate profile page.
Summary for 011316
| Tradename: | TEMARIL |
| Applicant: | Allergan Herbert |
| Ingredient: | trimeprazine tartrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011316
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 2.5MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | EQ 2.5MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 5MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
